HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

The present invention encompasses compounds of the formula (I) (see formula I) wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to Bruton's tyrosine kinase (BTK), and processes for making these compounds, pharmaceutical preparations co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LARSON, ERIC THOMAS, SHEN, YUE, BOSANAC, TODD, BENTZIEN, JOERG, TSCHANTZ, MATT AARON, BURKE, MICHAEL JASON, FRYER, RYAN MICHAEL, MAO, WANG, SOLEYMANZADEH, FARIBA, MCKIBBEN, BRYAN PATRICK
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention encompasses compounds of the formula (I) (see formula I) wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to Bruton's tyrosine kinase (BTK), and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use. La présente invention concerne des composés de formule (I) dans laquelle les groupes R1, Cy, et Y sont tels que définis ici, lesdits composés étant appropriés pour le traitement de maladies liées à la BTK. L'invention porte en outre sur un procédé de production de ces composés, sur des préparations pharmaceutiques contenant lesdits et sur leurs procédés d'utilisation.